Form 4: Director Howard Slayen Sells Aehr Test Systems Shares

Aehr Test Systems director Howard T. Slayen sold 6,819 shares of common stock on May 13, 2026.

Summary

• Director Howard T. Slayen disposed of 6,819 shares of Aehr Test Systems common stock.
• The transaction was executed at a price of $104.73 per share.
• Following this transaction, the director retains beneficial ownership of 169,709 shares.
• The reported total includes shares subject to unvested restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine disclosure of an insider transaction without accompanying negative operational news.

Positives

• The director maintains a significant remaining equity stake of 169,709 shares in the company.

Negatives

• The transaction represents a divestment of equity by a member of the board of directors.

Risks

• Insider selling can sometimes be perceived by the market as a lack of confidence in near-term share price appreciation.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that insider selling is a common occurrence for liquidity or portfolio rebalancing purposes and does not necessarily reflect a change in the company's fundamental business outlook within the semiconductor test equipment sector.

Comparison to Industry Standards

• Insider transactions are standard regulatory disclosures for publicly traded companies in the semiconductor equipment industry.
• The scale of the sale relative to the director's total holdings is consistent with typical portfolio management practices.

Stakeholder Impact

• Shareholders should note the change in insider ownership, though it is not inherently indicative of company performance.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Aehr Test Systems, AEHR, Insider Trading, Form 4, Director Sale, Semiconductor Equipment